Cantel Medical Corp.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Cantel Medical Corp.
The Belgium-headquartered group is pulling the plug on its dry AMD research efforts and investments in cancer venture Oncurious to focus on two early-stage compounds that show promise for diabetic macular edema and other retinal diseases.
Dealmaking Quarterly Statistics, Q1 2021: Boston Scientific, Roche Start The Year With Billion-Dollar-Plus Acquisitions
During the first quarter, medical device company mergers and acquisition totalled $10.2bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $5bn.
Cardinal said it remains “committed to its medical distribution and global medical products businesses” despite the divesture of Cordis.
A financing round that was significantly oversubscribed by new and existing investors will help advance the Oxford-headquartered biotech's exosome therapeutics into the clinic and expand its technology platform.
- Infection Control-Sterilization
- Other Names / Subsidiaries
- Accutron, Inc.
- Aexis Medical BVBA
- Hu-Friedy Corporation
- JetPrep Ltd.
- Medical Innovations Group Holdings Limited,